Ger Pruijn, Professor of Autoimmune Diseases at Radboud University, will present the Novio Catalpa solution during an international scientific conference session focused on novel frontiers in rheumatoid arthritis.

In his presentation, Prof. Pruijn will introduce a nanobody-based hemagglutination assay for the rapid detection of anti-citrullinated protein antibodies (ACPA). This innovative point-of-care diagnostic technology enables fast, simple, and early detection of rheumatoid arthritis, with significant potential clinical impact.

When
Sunday, 17 May 2026, Session Time: 12:30 – 13:30

Where
Room: Station 01
Session: Rheumatoid Arthritis: Novel Frontiers

What
Presentation: Rapid Detection of Anti-Citrullinated Protein Antibodies (ACPA) by Nanobody-Based Hemagglutination on Cards
(Part of the Novio Catalpa technology)